Determining Whether to Submit an ANDA or a 505(b)(2) Application
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 10, 2019
April 15, 2020
c04d36f1-c78a-4aaf-8e45-6a99420cf632
Related Documents
Sunscreen Innovation Act: Withdrawal of a 586A Request or Pending Request Guidance for Industry
Guidance DocumentOctober 11, 2016Center for Drug Evaluation and Research
ANDA Submissions -- Refuse-to-Receive Standards Rev2
Guidance DocumentDecember 28, 2016Center for Drug Evaluation and Research
Oncology Pharmaceuticals: Reproductive Toxicity Testing and Labeling Recommendations Guidance for Industry: Guidance for Industry
Guidance DocumentMay 10, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox